{"filing":{"accession_number":"0001193125-26-284089","cik":"0001662774","ticker":"QNCX","company_name":"Quince Therapeutics, Inc.","form":"8-K","filing_date":"2026-06-26","report_date":null,"primary_document":"d168420d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1662774/000119312526284089/d168420d8k.htm"},"events":[{"id":14141,"run_id":12578,"accession_number":"0001193125-26-284089","anchor_item_number":"3.03","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"summary":"Quince Therapeutics effectuated a 1-for-20 reverse stock split on June 26, 2026, pursuant to stockholder approval obtained on June 11, 2026, via a Certificate of Amendment filed with Delaware. The reverse split modifies the capital structure and trading characteristics of the company's common stock by combining shares, though it does not alter ownership percentages or the fundamental rights and preferences of the securities.","company_name":"Quince Therapeutics, Inc.","ticker":"QNCX","filing_date":"2026-06-26","form":"8-K","submitted_at":null,"items":[{"id":11486,"accession_number":"0001193125-26-284089","item_number":"3.03","item_title":"Material Modification to Rights of Security Holders","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"This disclosure concerns the implementation of a reverse stock split (1-for-20) that was previously approved by stockholders on June 11, 2026, and has now been effectuated via a Certificate of Amendment filed with Delaware on June 26, 2026. While a reverse stock split modifies the rights of security holders by combining shares, it is fundamentally a governance and capital structure action rather than a material event in the traditional sense (not a restatement, impairment, covenant breach, or M\u0026A activity). The split affects all stockholders uniformly and does not change ownership percentages or the rights/preferences of common stock itself. This is a governance-related event that does not fit the specific named categories, making it appropriate for governance_other. It is material because it affects the trading characteristics and share count of the company's securities.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-26T13:19:39.226750+00:00","company_name":"","ticker":null,"filing_date":""},{"id":11487,"accession_number":"0001193125-26-284089","item_number":"5.03","item_title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year","event_type":"governance_other","event_domain":"governance","is_material":false,"confidence":0.85,"reasoning":"Item 5.03 discloses amendments to articles of incorporation or bylaws, which is a governance matter. The filing merely incorporates Item 3.03 by reference without providing substantive detail in this section. Without visibility into Item 3.03's content, the amendment appears to be a routine corporate governance filing rather than a material event affecting investor assessment.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-26T13:19:39.226750+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":11486,"accession_number":"0001193125-26-284089","item_number":"3.03","item_title":"Material Modification to Rights of Security Holders","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"This disclosure concerns the implementation of a reverse stock split (1-for-20) that was previously approved by stockholders on June 11, 2026, and has now been effectuated via a Certificate of Amendment filed with Delaware on June 26, 2026. While a reverse stock split modifies the rights of security holders by combining shares, it is fundamentally a governance and capital structure action rather than a material event in the traditional sense (not a restatement, impairment, covenant breach, or M\u0026A activity). The split affects all stockholders uniformly and does not change ownership percentages or the rights/preferences of common stock itself. This is a governance-related event that does not fit the specific named categories, making it appropriate for governance_other. It is material because it affects the trading characteristics and share count of the company's securities.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-26T13:19:39.226750+00:00","company_name":"Quince Therapeutics, Inc.","ticker":"QNCX","filing_date":"2026-06-26"},{"id":11487,"accession_number":"0001193125-26-284089","item_number":"5.03","item_title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year","event_type":"governance_other","event_domain":"governance","is_material":false,"confidence":0.85,"reasoning":"Item 5.03 discloses amendments to articles of incorporation or bylaws, which is a governance matter. The filing merely incorporates Item 3.03 by reference without providing substantive detail in this section. Without visibility into Item 3.03's content, the amendment appears to be a routine corporate governance filing rather than a material event affecting investor assessment.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-26T13:19:39.226750+00:00","company_name":"Quince Therapeutics, Inc.","ticker":"QNCX","filing_date":"2026-06-26"}]}